ArticleOncoTargets and therapy2016

The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer.

Yoon Ji Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.